Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]

Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Carlo Bodenizza, Mario Carotenuto, Angela Michele Corella

Research output: Contribution to journalArticle

Abstract

Fifty-one patients with relapsed or resistant multiple myeloma received clarithromycin p.o. at the dose of 500 mg b.i.d Thirteen patients did not complete the planned therapeutic program of 12 weeks due to side effects or progression. Among the 38 evaluable patients, objective or minor responses occurred in one and two patients, respectively. Our data do not support the use of clarithromycin for the treatment of advanced multiple myeloma.

Original languageEnglish
Pages (from-to)658-659
Number of pages2
JournalHaematologica
Volume87
Issue number6
Publication statusPublished - 2002

Fingerprint

Clarithromycin
Multiple Myeloma
Therapeutics

Keywords

  • Clarithromycin
  • Myeloma

ASJC Scopus subject areas

  • Hematology

Cite this

Musto, P., Falcone, A., Sanpaolo, G., Bodenizza, C., Carotenuto, M., & Corella, A. M. (2002). Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]. Haematologica, 87(6), 658-659.

Inefficacy of clarithromycin in advanced multiple myeloma : A definitive report [1]. / Musto, Pellegrino; Falcone, Antonietta; Sanpaolo, Grazia; Bodenizza, Carlo; Carotenuto, Mario; Corella, Angela Michele.

In: Haematologica, Vol. 87, No. 6, 2002, p. 658-659.

Research output: Contribution to journalArticle

Musto, P, Falcone, A, Sanpaolo, G, Bodenizza, C, Carotenuto, M & Corella, AM 2002, 'Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]', Haematologica, vol. 87, no. 6, pp. 658-659.
Musto P, Falcone A, Sanpaolo G, Bodenizza C, Carotenuto M, Corella AM. Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]. Haematologica. 2002;87(6):658-659.
Musto, Pellegrino ; Falcone, Antonietta ; Sanpaolo, Grazia ; Bodenizza, Carlo ; Carotenuto, Mario ; Corella, Angela Michele. / Inefficacy of clarithromycin in advanced multiple myeloma : A definitive report [1]. In: Haematologica. 2002 ; Vol. 87, No. 6. pp. 658-659.
@article{2981d820385e4661bc961fc5740e0b15,
title = "Inefficacy of clarithromycin in advanced multiple myeloma: A definitive report [1]",
abstract = "Fifty-one patients with relapsed or resistant multiple myeloma received clarithromycin p.o. at the dose of 500 mg b.i.d Thirteen patients did not complete the planned therapeutic program of 12 weeks due to side effects or progression. Among the 38 evaluable patients, objective or minor responses occurred in one and two patients, respectively. Our data do not support the use of clarithromycin for the treatment of advanced multiple myeloma.",
keywords = "Clarithromycin, Myeloma",
author = "Pellegrino Musto and Antonietta Falcone and Grazia Sanpaolo and Carlo Bodenizza and Mario Carotenuto and Corella, {Angela Michele}",
year = "2002",
language = "English",
volume = "87",
pages = "658--659",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "6",

}

TY - JOUR

T1 - Inefficacy of clarithromycin in advanced multiple myeloma

T2 - A definitive report [1]

AU - Musto, Pellegrino

AU - Falcone, Antonietta

AU - Sanpaolo, Grazia

AU - Bodenizza, Carlo

AU - Carotenuto, Mario

AU - Corella, Angela Michele

PY - 2002

Y1 - 2002

N2 - Fifty-one patients with relapsed or resistant multiple myeloma received clarithromycin p.o. at the dose of 500 mg b.i.d Thirteen patients did not complete the planned therapeutic program of 12 weeks due to side effects or progression. Among the 38 evaluable patients, objective or minor responses occurred in one and two patients, respectively. Our data do not support the use of clarithromycin for the treatment of advanced multiple myeloma.

AB - Fifty-one patients with relapsed or resistant multiple myeloma received clarithromycin p.o. at the dose of 500 mg b.i.d Thirteen patients did not complete the planned therapeutic program of 12 weeks due to side effects or progression. Among the 38 evaluable patients, objective or minor responses occurred in one and two patients, respectively. Our data do not support the use of clarithromycin for the treatment of advanced multiple myeloma.

KW - Clarithromycin

KW - Myeloma

UR - http://www.scopus.com/inward/record.url?scp=0036278985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036278985&partnerID=8YFLogxK

M3 - Article

C2 - 12031924

AN - SCOPUS:0036278985

VL - 87

SP - 658

EP - 659

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 6

ER -